STRS Ohio
KPTI icon

STRS Ohio’s Karyopharm Therapeutics KPTI Stock Holding History

STRS Ohio’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$662K Buy
+542,500
New +$2.22M ﹤0.01% 1108
2019
Q1 		– Sell
-1,613
Closed -$226K – 2078
2018
Q4 		$226K Sell
1,613
-114
-7% -$19.2K ﹤0.01% 1610
2018
Q3 		$441K Hold
1,727
– – ﹤0.01% 1440
2018
Q2 		$440K Buy
+1,727
New +$427K ﹤0.01% 1436
2014
Q1 		– Sell
-207
Closed -$105K – 1729
2013
Q4 		$71K Buy
+207
New +$57.2K ﹤0.01% 1603

Other funds holding KPTI

China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
MB, Levis & Associates
MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

STRS Ohio's KPTI Position: Q3 2026 in Review

STRS Ohio opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 542,500 shares worth $662K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings. This is a return to the name: STRS Ohio previously reported a position in KPTI as recently as Q4 2018.

STRS Ohio first reported a position in KPTI in Q4 2013 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

  • STRS Ohio held 542,500 shares of Karyopharm Therapeutics worth $662K as of Q3 2026.
  • Karyopharm Therapeutics was a new STRS Ohio position in Q3 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1108 holding.
  • STRS Ohio first reported a position in Karyopharm Therapeutics in Q4 2013 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.